BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $566,000 | -58.8% | 3,881 | -66.5% | 0.00% | 0.0% |
| Q1 2022 | $1,373,000 | -58.5% | 11,580 | -70.0% | 0.00% | -83.3% |
| Q4 2020 | $3,307,000 | +369.7% | 38,581 | +256.3% | 0.01% | +200.0% |
| Q3 2020 | $704,000 | +4.9% | 10,829 | +18.0% | 0.00% | -33.3% |
| Q2 2020 | $671,000 | +57.5% | 9,180 | -26.7% | 0.00% | 0.0% |
| Q1 2020 | $426,000 | -85.6% | 12,529 | -77.0% | 0.00% | -85.0% |
| Q4 2019 | $2,967,000 | -19.6% | 54,504 | -38.4% | 0.02% | -33.3% |
| Q3 2019 | $3,689,000 | -18.1% | 88,421 | -14.0% | 0.03% | -26.8% |
| Q2 2019 | $4,504,000 | +6937.5% | 102,847 | +5942.7% | 0.04% | +4000.0% |
| Q3 2018 | $64,000 | -67.0% | 1,702 | -65.3% | 0.00% | -50.0% |
| Q2 2018 | $194,000 | -88.7% | 4,904 | -92.6% | 0.00% | -88.2% |
| Q1 2018 | $1,713,000 | – | 66,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |